Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Agreed.
Time for a healthy breather, some backing and filling.
I guess we have to remember there are plenty of LONG H/F, like Baker Brothers. When the story is good enough, they in turn like to "stick" it to the shorts, and cause them as much pain on the way up, as shortie caused on the way down. But we need the news ans the fun begins.
TC
Lets see who if the shorts can pain the tape at the close. Looks like they are putting up quite a fight. Hoping for news soon......
Thanks, GLTU also!
It is entirely possible that news has leaked. The price has come a long way. I also hope you are spot-on.
Still believe a lot of daytraders are in here today.
Hope I am wrong, and we have news very soon.
GLTU
I would also think the day traders have moved in here.
They buy and sell to make a few pennies.
Let me try this again so I don't get yet another post deleted.
Please, oh Please stop spreading FUD about the trial stopping!
It has not been stopped.
No need to imagine. It will be crickets.
Please put a quarter on the stylus arm on the turntable, because this question is skipping badly, and ad nauseum.
Btw, I thought this was the NWBO board.
Whoever asked for the total, asked for fully Diluted Shares.
This includes ALL outstanding warrants. Senti is correct in her total.
The point is not if Stifel sold or not. He was on the call for a reason, maybe thinking of getting back in. He asked a legitimate question, and did not deserve to get dressed down. Don't care if this has been discussed before. Any new fund or brokerage thinking of getting in will ask this question. It is called due diligence.
If this is going to be the answer going forward, it is a problem.
Also, the analyst from Stifel was not happy with Jerry's lecture to him. Careful, you don't have many analysts left.
I believe he scolded Brian Marckx about this same subject last call.
Didn't hear him today.....Hmmmmmmmm.
I heard Shelton acting like a baby when questioned about all the options. He did the same on the last call, but this was worse.
If you are gonna give away options like candy, then you had better earn them, warehousemen included. Or stop whining when asked about them, because your real bosses, the shareholders are not happy about them!
BTW, if he thinks we believe that he has no say in his compensation, that it is entirely up to the BOD, hey Jerry, we aren't that STUPID!
Go BLUE!!!!!!!!
Personally don't think 3 million this quarter. New biologic started late in Q1. Now I will ruminate that it may come close in Q2.
But, that is just a guess, and that guess and $2.11 will get you an extra large coffee at Tim Hortons.........
This also seems to be in addition to the biologic company mentioned in the latest conference call!
My thoughts exactly.
First, the product has 4 billion in sales not 3.
I can tell you never invest in biotech, esprcially immunotherapy,
because there are always delays. Especially immunotherapy, because it is so new.
If you will not take the time to listen to the call or even read it, I don't know what to tell you! You just start a rant and go off, because the stock is not $50.00 yet. I have been in this stock for over 6 years, I know not as long as you, but I will be patient a while longer.
Clinical trials as they relate to us through progression generally and for a revenue ramp moving to the clinical stages of development to commercialization. For example, revenue to Cryoport for Phase I trials might typically range from $15,000 to $75,000 annually. For Phase II $50,000 to $150,000 and for Phase III $200,000 to $1 million, and for commercialization $3 million to $20 million-plus. So you can readily see why I say we are just at the tip of the iceberg[/b
Do you see it says ANNUALLY.
It takes big pharma a very long time to seal a deal, especially one with a 30 million marketcap.
Reread what I posted. It says the approved product has sales of 4 billion, not the pharma total revenue.
In Q1 of FY 2017 signed first commercial support program with a big pharma company for an approved product with $4 billion in revenue.
As far as a new management team, how long do you think it will take them to build sales. Will all the progress made with the phase 3 trials be lost with a new management team. Trust is a big factor here.
Would it take 3 more years to get back to where we are now?
I know it is frustrating, but how easy do you think it is to get a major pharma to sign on with a company with less than a 30 million market cap. I think this goes to trust and the fact that Rathman from Amgen lineage is on board.
If you want change, what will you do if you get another Stambaugh?
I will take this management team. We are in growth mode, and when the market realizes this, the price will react.
This did not sound like an excuse to me......
In Q1 of FY 2017 signed first commercial support program with a big pharma company for an approved product with $4 billion in revenue.
Someone needs a new calendar....
http://www.nwbio.com/nw-bio-featured-presentations-american-association-cancer-research-annual-meeting/
The Clinical Trial Investigator at MD Anderson will present a poster on the DCVax-Direct program, entitled Clinical and Immunopathological Effects Following Image-Guided Intratumoral Injection Of Activated, Autologous Dendritic Cells In Patients With Advanced Solid Cancers. The poster will provide information about immune responses in the patients in the Phase I trial overall, as well as case study information. This presentation will take place in Section 26 of Halls B–E of the Convention Center, from 1:00 p.m. to 5:00 p.m. on Monday, April 20 (the same Hall and time period as Dr. Bosch’s poster presentation.
http://www.nwbio.com/nw-bio-presenting-new-dcvax-direct-poster-at-the-inaugural-international-cancer-immunotherapy-conference-translating-science-into-survival-in-new-york-city-on-wednesday-september-16-2015/
Someone still bought 8 million shares in the last 2 days and did not tank the price. Sounds like someone is accumulating.
Nobody here wants to talk to you either. We buy our WHINE at the liquor store. Maybe you should try to whine to the Titanic captain's spirit. Maybe you can straighten him out like you are going to straighten out NWBO. LOLOLOL
At least 6 months.
If this is the best you can muster, it is time to retake Bashing 101.
Whatever....everyone has their opinion.
I have to believe the deal with Worthington Industries and trying to raise more cash portends to something big. I think they maybe need to expand their dewar fleet. Just my opinion, nothing more.
BTW, I think they have until June 30th to report their year end sales. Probably waiting for the rights offfering to close, which is June 20th I believe.
Whatever, you are best a trader, which is proven out by your comments.
Don't hear much positive from you about NWBO. I would sure hate to see your comments if you were short.
Nice to see you are a "REAL COMMITTED LONG."
LOLOLOLOL
Whatever. There are way too many "LONGS" here, who continually bash the stock. Why would you own a company, and hope for the price to appreciate, and then continually look for anything negative. This is akin to owning a business, and then going on TV to tell the world how great your competition is, and that your company has no chance of success. There are more than a few of these characters here. Some have been here long term. Maybe they are just in it for themselves, and are flipping the stock. It is kinda sad that they think anyone who has been here a while, cannot see right through this. I guess I need more ignores.
No paranoia. Just seen this song and dance go on forever,
Posters have multiple aliases and cannot keep them straight.
Maybe you are paranoid?
Thing that make you go Hmmmmmm.....
Funny how 3 well known bashers are now gone, and there is a new one doing the non stop bashing, claiming to be long and buying, while bashing non stop......HMMMMMMMMMMM!
If you do not acknowledge a bear market in biotech, you live in another solar systm.
I beg to differ. The licensee does the negotiating. Why would NWBO build out all the operations to manufacture if UCLA controlled the purse strings. UCLA, I would think, has a deal for a percentage of what is sold.
Just responding to a misguided comment about a reverse split coming.
Then comes your negative drivel. Classic!
This would take 180 days to be delisted. Happens all the time. Extensions from Nasdaq.
All of the fines are a cost of doing business. The firm doesn't pay it anyway the clients do one way or another. The only way to put and end to all of this malfeasance, is for people responsible to go to JAIL. This is what yours and my fate would be. The money is irrelevant.